CO4750713A1 - MACROLIDES - Google Patents
MACROLIDESInfo
- Publication number
- CO4750713A1 CO4750713A1 CO96034982A CO96034982A CO4750713A1 CO 4750713 A1 CO4750713 A1 CO 4750713A1 CO 96034982 A CO96034982 A CO 96034982A CO 96034982 A CO96034982 A CO 96034982A CO 4750713 A1 CO4750713 A1 CO 4750713A1
- Authority
- CO
- Colombia
- Prior art keywords
- inclusive
- positions
- acid residue
- macrocyclic ring
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un macrólido en el cual las posiciones 2 a 6 inclusive delanillo macrocíclico están proporcionadas por un residuo de ácido piperidacinil carboxílico; y/o ii) las posiciones 7 a 9 inclusive del anillo macrocíclico están proporcionadas por un residuo de ácido alfa-amino aromático; y/o iii) las posiciones 10 a 12 inclusive del anillo macrocíclico están proporcionadas por un residuo de ácido alfa-amino alifático, en forma libre o protegida, o una de sus sales.A macrolide in which positions 2 to 6 inclusive of the macrocyclic ring are provided by a piperidacinyl carboxylic acid residue; and / or ii) positions 7 to 9 inclusive of the macrocyclic ring are provided by an alpha-amino aromatic acid residue; and / or iii) positions 10 to 12 inclusive of the macrocyclic ring are provided by an alpha-amino aliphatic acid residue, in free or protected form, or a salt thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9513596.8A GB9513596D0 (en) | 1995-07-04 | 1995-07-04 | Organic compounds |
GBGB9515495.1A GB9515495D0 (en) | 1995-07-28 | 1995-07-28 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4750713A1 true CO4750713A1 (en) | 1999-03-31 |
Family
ID=26307320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO96034982A CO4750713A1 (en) | 1995-07-04 | 1996-07-04 | MACROLIDES |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0836616A1 (en) |
JP (1) | JPH11509092A (en) |
KR (1) | KR19990028724A (en) |
CN (1) | CN1193979A (en) |
AR (1) | AR006514A1 (en) |
AU (1) | AU708004B2 (en) |
BR (1) | BR9609324A (en) |
CA (1) | CA2224715A1 (en) |
CO (1) | CO4750713A1 (en) |
CZ (1) | CZ424297A3 (en) |
HU (1) | HUP9802320A3 (en) |
IL (1) | IL122844A0 (en) |
NO (1) | NO980016L (en) |
PL (1) | PL324346A1 (en) |
SK (1) | SK498A3 (en) |
TR (1) | TR199800001T1 (en) |
WO (1) | WO1997002285A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124453A (en) * | 1995-07-04 | 2000-09-26 | Novartis Ag | Macrolides |
GB9811854D0 (en) * | 1998-06-02 | 1998-07-29 | Ciba Geigy Ag | Organic compounds |
US7368423B1 (en) * | 2001-12-05 | 2008-05-06 | The Scripps Research Institute | Composition and method for treating chronic allograft rejection |
US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
RU2427372C2 (en) | 2005-06-17 | 2011-08-27 | Новартис Аг | Application of sangliferin for treating hepatitis c virus |
US8067024B2 (en) | 2006-02-10 | 2011-11-29 | Medtronic Vascular, Inc. | Medical devices to prevent or inhibit restenosis |
CN101289440B (en) * | 2007-06-29 | 2010-08-25 | 中国热带农业科学院热带生物技术研究所 | Polyene macrocyclic compounds, preparation thereof and applications |
CN102224242B (en) * | 2008-09-24 | 2014-09-24 | 中国科学院上海有机化学研究所 | Novel gene cluster |
WO2011098805A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
BR112012019866A8 (en) | 2010-02-09 | 2017-12-26 | Biotica Tech Limited | COMPOUND, USE THEREOF, PHARMACEUTICAL COMPOSITION, AND PROCESS FOR PREPARING A COMPOUND |
WO2011098808A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
GB201008123D0 (en) | 2010-05-17 | 2010-06-30 | Biotica Tech Ltd | Novel compounds |
UY33775A (en) | 2010-12-10 | 2012-07-31 | Gilead Sciences Inc | MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND THEIR USES |
CA3028414C (en) | 2010-12-20 | 2021-01-26 | Neurovive Pharmaceutical Ab | Sanglifehrin derivatives and methods for their production |
JO3063B1 (en) | 2011-03-29 | 2017-03-15 | Neurovive Pharmaceutical Ab | Novel compound and methods for its production |
GB201118334D0 (en) | 2011-10-24 | 2011-12-07 | Biotica Tech Ltd | Novel dosage form |
PT2861604T (en) * | 2012-06-08 | 2017-05-05 | Gilead Sciences Inc | Macrocyclic inhibitors of flaviviridae viruses |
AR091279A1 (en) * | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE |
MX2014014768A (en) * | 2012-06-08 | 2015-05-11 | Gilead Sciences Inc | Macrocyclic inhibitors of flaviviridae viruses. |
EP3541388A1 (en) | 2016-11-18 | 2019-09-25 | Neurovive Pharmaceutical AB | Use of sanglifehrin macrocyclic analogues as anticancer compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9318144D0 (en) * | 1993-09-01 | 1993-10-20 | Sandoz Ltd | Organic compounds |
WO1995015328A1 (en) * | 1993-11-30 | 1995-06-08 | Abbott Laboratories | Macrocyclic immunomodulators with novel cyclohexyl ring replacements |
-
1996
- 1996-07-03 AR ARP960103427A patent/AR006514A1/en unknown
- 1996-07-04 WO PCT/EP1996/002952 patent/WO1997002285A1/en not_active Application Discontinuation
- 1996-07-04 CZ CZ974242A patent/CZ424297A3/en unknown
- 1996-07-04 JP JP9504832A patent/JPH11509092A/en active Pending
- 1996-07-04 PL PL96324346A patent/PL324346A1/en unknown
- 1996-07-04 AU AU65193/96A patent/AU708004B2/en not_active Ceased
- 1996-07-04 CN CN96196487A patent/CN1193979A/en active Pending
- 1996-07-04 IL IL12284496A patent/IL122844A0/en unknown
- 1996-07-04 TR TR1998/00001T patent/TR199800001T1/en unknown
- 1996-07-04 SK SK4-98A patent/SK498A3/en unknown
- 1996-07-04 EP EP96924886A patent/EP0836616A1/en not_active Withdrawn
- 1996-07-04 BR BR9609324A patent/BR9609324A/en not_active Application Discontinuation
- 1996-07-04 HU HU9802320A patent/HUP9802320A3/en unknown
- 1996-07-04 CO CO96034982A patent/CO4750713A1/en unknown
- 1996-07-04 KR KR1019980700022A patent/KR19990028724A/en not_active Application Discontinuation
- 1996-07-04 CA CA002224715A patent/CA2224715A1/en not_active Abandoned
-
1998
- 1998-01-02 NO NO980016A patent/NO980016L/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU708004B2 (en) | 1999-07-29 |
JPH11509092A (en) | 1999-08-17 |
TR199800001T1 (en) | 1998-04-21 |
BR9609324A (en) | 1999-05-25 |
AR006514A1 (en) | 1999-09-08 |
AU6519396A (en) | 1997-02-05 |
CZ424297A3 (en) | 1998-04-15 |
KR19990028724A (en) | 1999-04-15 |
IL122844A0 (en) | 1998-08-16 |
PL324346A1 (en) | 1998-05-25 |
SK498A3 (en) | 1998-07-08 |
NO980016L (en) | 1998-03-02 |
MX9800217A (en) | 1998-07-31 |
NO980016D0 (en) | 1998-01-02 |
HUP9802320A2 (en) | 1999-02-01 |
HUP9802320A3 (en) | 1999-03-29 |
EP0836616A1 (en) | 1998-04-22 |
CN1193979A (en) | 1998-09-23 |
CA2224715A1 (en) | 1997-01-23 |
WO1997002285A1 (en) | 1997-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4750713A1 (en) | MACROLIDES | |
IT1272036B (en) | REGISTRATION SYSTEM FOR A PRODUCTION LINE. | |
UY26380A1 (en) | FAB I INHIBITORS | |
ES2138993T3 (en) | HALICONDRINAS: MACROLIDES OF POLYETER CITOTOXICOS. | |
HRP20030430B1 (en) | Macrolide solvates | |
BR0113634A (en) | Cephalosporin antibiotics and their prodrugs | |
HRP20000400B1 (en) | Transmucosal formulations of levosimendal | |
FR2713086B1 (en) | New cosmetic compositions containing simple polyols. | |
PT1217898E (en) | IMPROVED STORAGE HARD CARAMELS | |
ES2014311B3 (en) | THE NICKEL-CHROME-IRON AUSTENITIC ALLOY STRUCTURE APPARATUS. | |
NO20001783L (en) | Antifouling agents containing thiacloprid | |
FI880338A (en) | FOERFARANDE FOER FOERISOMERISATION AV HUMLE VID FRAMSTAELLNING AV DRYCKER, SPECIELLT OEL. | |
ES2101894T3 (en) | THERMOSTABILIZATION OF AROMATIC POLYCARBONATES. | |
DE68911223D1 (en) | Soft magnetic, iron-based alloy. | |
GT200000053S (en) | TOOTHBRUSH HEAD DESIGN. | |
AR247215A1 (en) | New antibiotic n-acetyl-benanomicin b, and the production and uses thereof | |
DE3866895D1 (en) | COLOR CATHODE JET PIPES. | |
FI921612A0 (en) | FOERFARANDE FOER KONTINUERLIG MOGNANDE OEL. | |
UA46841S (en) | 1.-7. LABEL ON THE BOTTLE | |
EA200200269A1 (en) | DEVICE FOR IMAGE SIGNS | |
MX9201610A (en) | PROCESS FOR THE TREATMENT OF AN ARGENTIFIER ALLOY. | |
ITTO940747A0 (en) | IMPROVED CALCINATION PROCEDURE ASSISTED BY ENZYMES. | |
ITRM930022V0 (en) | PERSONAL LIFTING BY DR. BENATOUIL. | |
ES1023501Y (en) | ADVERTISING KEY RING. | |
TR200102093T2 (en) | Organ-preserving solutions |